Adolescents' experience of living with X-linked hypophosphataemia (XLH): a mixed-methods analysis of those who continued and discontinued burosumab treatment after end of skeletal growth.

Saraff V, Arango-Sancho P, Bacchetta J, Boot AM, Burren CP, Chinoy A, Dharmaraj P, Gómez Llorente MA, González Rodríguez JD, Gueorguieva I, Hayes W, Schnabel D, Duro HR, Davies EH, Komarzynski S, Rylands AJ, Sandilands K, Ishii H, Williams A, Selveindran S, Barlassina A, Bowden A, Linglart A

Open source

DOI: 10.1186/s13023-026-04244-2
Published: 2026 Feb 3
Container: Orphanet journal of rare diseases
Publisher: Not recorded
Open access: yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1186/s13023-026-04244-2,
  title = {Adolescents' experience of living with X-linked hypophosphataemia (XLH): a mixed-methods analysis of those who continued and discontinued burosumab treatment after end of skeletal growth.},
  author = {Saraff V and Arango-Sancho P and Bacchetta J and Boot AM and Burren CP and Chinoy A and Dharmaraj P and Gómez Llorente MA and González Rodríguez JD and Gueorguieva I and Hayes W and Schnabel D and Duro HR and Davies EH and Komarzynski S and Rylands AJ and Sandilands K and Ishii H and Williams A and Selveindran S and Barlassina A and Bowden A and Linglart A},
  year = {2026},
  journal = {Orphanet journal of rare diseases},
  doi = {10.1186/s13023-026-04244-2},
  url = {https://doi.org/10.1186/s13023-026-04244-2}
}

RIS

TY  - JOUR
TI  - Adolescents' experience of living with X-linked hypophosphataemia (XLH): a mixed-methods analysis of those who continued and discontinued burosumab treatment after end of skeletal growth.
AU  - Saraff V
AU  - Arango-Sancho P
AU  - Bacchetta J
AU  - Boot AM
AU  - Burren CP
AU  - Chinoy A
AU  - Dharmaraj P
AU  - Gómez Llorente MA
AU  - González Rodríguez JD
AU  - Gueorguieva I
AU  - Hayes W
AU  - Schnabel D
AU  - Duro HR
AU  - Davies EH
AU  - Komarzynski S
AU  - Rylands AJ
AU  - Sandilands K
AU  - Ishii H
AU  - Williams A
AU  - Selveindran S
AU  - Barlassina A
AU  - Bowden A
AU  - Linglart A
PY  - 2026
JO  - Orphanet journal of rare diseases
DO  - 10.1186/s13023-026-04244-2
UR  - https://doi.org/10.1186/s13023-026-04244-2
ER  -

APA

V, S., P, A., J, B., AM, B., CP, B., A, C., P, D., MA, G. L., JD, G. R., I, G., W, H., D, S., HR, D., EH, D., S, K., AJ, R., K, S., H, I., A, W., S, S., A, B., A, B., & A, L. (2026). Adolescents' experience of living with X-linked hypophosphataemia (XLH): a mixed-methods analysis of those who continued and discontinued burosumab treatment after end of skeletal growth.. Orphanet journal of rare diseases. https://doi.org/10.1186/s13023-026-04244-2

Source records

pubmed · retrieved 2026-09-26T16:26:02.578Z
europe-pmc · retrieved 2026-09-26T16:26:02.595Z
doaj · retrieved 2026-09-26T16:26:02.590Z
hal · retrieved 2026-09-26T16:26:02.631Z